secwatch.observer — SEC 8-K summary
======================================

Issuer:     Quoin Pharmaceuticals, Ltd. (QNRX)
CIK:        0001671502
Form:       8-K
Filed at:   2024-05-03T23:59:59+00:00
Accession:  0001104659-24-057008
Event type: regulatory
Sentiment:  negative
Materiality: 0.50
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Quoin Pharma receives Nasdaq notice for non-compliance with $1.00 minimum bid price
--------------------------------------------------------------------------------

- Received Nasdaq notice on April 29, 2024 for failing to maintain minimum bid price of $1.00 per ADS for 31 consecutive business days through April 26, 2024.
- No immediate effect on listing; ADSs continue trading on Nasdaq Capital Market under symbol QNRX.
- Company has 180 calendar days, until October 28, 2024, to regain compliance by having closing bid price >= $1.00 for at least 10 consecutive business days.
- If not compliant by October 28, may be eligible for a second 180-day period if it meets other initial listing standards.
- Company will monitor bid price and consider available options to cure the deficiency.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1671502/000110465924057008/0001104659-24-057008-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1671502/000110465924057008/tm2413391d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-057008

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer